Longboard Pharmaceuticals的动态

We are pleased to announce the initiation of our Ph 3 DEEp OCEAN Study for individuals living with Developmental and Epileptic Encephalopathies (DEEs). We are very proud of the team for their hard work and dedication to the DEEp Program! https://bit.ly/3YKaNSk

  • 该图片无替代文字
Brett Bookser

Principal Research Analyst, Drug Discovery

1 周

Love the "ocean" shout out in the trial title!

赞
回复
Brad Levy

Brain Science Technologies / EEG to go/ Epilepsy Awareness Day @ Disneyland / EpilepsyExpo.org

2 周

I hope we'll be hearing more about this next week at the Epilepsy Awareness Day EXPO.

赞
回复
1 次回应
Lindsay Randall

Founder and CEO of registered non profit SLC6A1 Connect UK-AQ and Rare Disease Mum. Registered Children's Nurse @ NHS. Patient Advocate. Interested in Rare Disease, Epilepsy and Learning Disabilities.

2 周

Great news #SLC6A1 let's talk ??

赞
回复
Ben Payne

Global Life Sciences Development, FSP Portfolio, Sales & Client Engagement Professional

2 周

Well done! Chad Orevillo

赞
回复
1 次回应
Shahid Siddiqui

Global Medical Affairs - Specialty Care, Resp - GSK

2 周

Congrats Chad !

赞
回复
1 次回应
Linh Truong

Prev. @Longboard Pharmaceuticals Clin Ops | Community Impact through Science, Business, & Nonprofits | Pharmacology & Drug Development First Gen @ University of Southern California | Bank of America Student Leader 2023

2 周

Congratulations!!

赞
回复
1 次回应
Phil Perera M.D., MBA

Chief Medical Officer

2 周

Congrats!

赞
回复
1 次回应
查看更多评论

要查看或添加评论，请登录

最相关的动态

Longboard Pharmaceuticals

11,074 位关注者